Erratum: A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy (Journal of the American Chemical Society (2015) 137 (14854-14857) DOI: 10.1021/jacs.5b10182)
- Samuel G. Awuah
- , Yao Rong Zheng
- , Peter M. Bruno
- , Michael T. Hemann
- , Stephen J. Lippard
Research output: Contribution to journal › Comment/debate
2
Scopus
citations